Randomized dose-comparison studies of intravitreous fomivirsen for treatment of cytomegalovirus retinitis that has reactivated or is persistently active despite other therapies in patients with AIDS11InternetAdvance publication at ajo.com Feb 8, 2002.Financial disclosures and conflict of interest statements are listed at the end of the article.Correspondence to Stephen L. Hutcherson, MBA, Cyclix Ltd. LLC, 11851 Rexmoor Drive, Richmond, VA 23236; fax: (804) 897-9544; e-mail: cyclix@comcast.netReprint requests to René Lanz, PhD, Novartis Ophthalmics AG, Grenzstrasse 10, CH-8180 Bülach, Switzerland; fax: (41) 1-862-0762; e-mail: rene.lanz@pharm.novartis.com